PPARG and intracerebral hemorrhage: PPARγ agonists also increased neuron survival anddecreased lesion sizes in models of Parkinson's disease [43, 46], central inflammation [34], intracerebral hemorrhage [38], and cerebral ischemia [5, 6, 31, 35].